Lipitor Lawsuits Move Forward, as Pfizer Seeks Dismissal of Texas Diabetes Claims Pending in Multidistrict Litigation, Bernstein Liebhard LLP Reports

Share Article

The Firm is evaluating Lipitor lawsuits on behalf of individuals who developed Type 2 diabetes, allegedly due to their use of the cholesterol-lowering statin medication.

Free Case Review
Our Firm has heard from a number of Lipitor patients who allege the statin caused the onset of Type 2 diabetes. As such, we are monitoring this litigation very closely.

Lipitor lawsuits ( that allege the cholesterol-lowering statin caused some patients to develop Type 2 diabetes continue to move forward in federal court, Bernstein Liebhard LLP reports. According to a Motion filed in the U.S. District Court, District of South Carolina, on October 3rd, Pfizer, Inc. is seeking the dismissal of at least 10 Lipitor diabetes claims filed in the federal multidistrict litigation on behalf of Texas residents. Among other things, the company asserts that under Texas law, manufacturers of prescription medications are not liable for product liability claims so long as warnings included on a drug’s label were approved by the U.S. Food & Drug Administration (FDA). (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502)

“Our Firm has heard from a number of Lipitor patients who allege the statin caused the onset of Type 2 diabetes. As such, we are monitoring this litigation very closely,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential case reviews to individuals who may have been harmed by Lipitor.

Lipitor Diabetes Litigation
Court documents indicate that at least 1,270 Lipitor lawsuits have been filed in the District of South Carolina on behalf of plaintiffs who allege the medication increases the risk that a patient will develop Type 2 diabetes. Among other things, the complaints accuse Pfizer of being aware of the association between the medication and diabetes, and of concealing this knowledge from doctors and patients.

According to court records, the Lipitor litigation has been growing since February 2012, when the U.S. Food & Drug Administration (FDA) ordered the manufacturers of statin drugs to include information on their labels regarding a possible association between their use and Type 2 diabetes. The FDA acted after a study published in JAMA: Internal Medicine indicated that women using the medications may be at an increased risk of developing the disease.** Plaintiffs who have filed Lipitor lawsuits maintain that the label modification instituted by Pfizer at that time was inadequate, and still does not sufficiently warn Lipitor users that they may be at increased risk for Type 2 diabetes.

Lipitor patients who allegedly developed Type 2 diabetes due to the statin medication may be entitled to bring their own claim against Pfizer. To learn more about filing a Lipitor lawsuit, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to obtain a free legal review.

*, JAMA Internal Medicine, January 2012

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website